{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:19:55Z","timestamp":1707524395228},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3,12]]},"DOI":"10.7759\/cureus.23090","type":"journal-article","created":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T11:41:00Z","timestamp":1647085260000},"source":"Crossref","is-referenced-by-count":0,"title":["Psoriasis and Myasthenia Gravis: A Common Th-17 Pathway"],"prefix":"10.7759","author":[{"given":"Fouad","family":"El Sayed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariam","family":"Kabbani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.4006","article-title":"Pathophysiology, clinical presentation, and treatment of psoriasis: a review","volume":"323","author":"Armstrong AW","year":"2020","unstructured":"Armstrong AW, Read C. Pathophysiology, clinical presentation, and treatment of psoriasis: a review. JAMA. 2020, 323:1945-60. 10.1001\/jama.2020.4006","journal-title":"JAMA"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1602678","article-title":"Myasthenia gravis","volume":"375","author":"Gilhus NE","year":"2016","unstructured":"Gilhus NE. Myasthenia gravis. N Engl J Med. 2016, 375:2570-81. 10.1056\/NEJMra1602678","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.15184","article-title":"Dendritic cells: the driver of psoriasis","volume":"47","author":"Wang A","year":"2020","unstructured":"Wang A, Bai Y. Dendritic cells: the driver of psoriasis. J Dermatol. 2020, 47:104-13. 10.1111\/1346-8138.15184","journal-title":"J Dermatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/cei.13546","article-title":"Roles of cytokines and T cells in the pathogenesis of myasthenia gravis","volume":"203","author":"Uzawa A","year":"2021","unstructured":"Uzawa A, Kuwabara S, Suzuki S, et al.. Roles of cytokines and T cells in the pathogenesis of myasthenia gravis. Clin Exp Immunol. 2021, 203:366-74. 10.1111\/cei.13546","journal-title":"Clin Exp Immunol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/nyas.13591","article-title":"An imbalance between regulatory T cells and T helper 17 cells in acetylcholine receptor-positive myasthenia gravis patients","volume":"1413","author":"Villegas JA","year":"2018","unstructured":"Villegas JA, Van Wassenhove J, Le Panse R, Berrih-Aknin S, Dragin N. An imbalance between regulatory T cells and T helper 17 cells in acetylcholine receptor-positive myasthenia gravis patients. Ann N Y Acad Sci. 2018, 1413:154-62. 10.1111\/nyas.13591","journal-title":"Ann N Y Acad Sci"},{"key":"ref6","article-title":"Coexistence of epilepsy, myasthenia gravis and psoriasis vulgaris","volume":"63","author":"Kwan SY","year":"2000","unstructured":"Kwan SY, Lin JH, Su MS. Coexistence of epilepsy, myasthenia gravis and psoriasis vulgaris. Zhonghua Yi Xue Za Zhi (Taipei). 2000, 63:153-7.","journal-title":"Zhonghua Yi Xue Za Zhi (Taipei)"},{"key":"ref7","article-title":"Myasthenia gravis and psoriasis vulgaris","volume":"14","author":"Koc F","year":"2009","unstructured":"Koc F, Yerdelen D. Myasthenia gravis and psoriasis vulgaris. Neurosciences (Riyadh). 2009, 14:175-7.","journal-title":"Neurosciences (Riyadh)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.12456","article-title":"Three cases of psoriasis vulgaris associated with myasthenia gravis","volume":"41","author":"Takahashi H","year":"2014","unstructured":"Takahashi H, Tsuji H, Iizuk H. Three cases of psoriasis vulgaris associated with myasthenia gravis. J Dermatol. 2014, 41:462-3. 10.1111\/1346-8138.12456","journal-title":"J Dermatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.15913","article-title":"Pathophysiology of psoriasis: a review","volume":"48","author":"Yamanaka K","year":"2021","unstructured":"Yamanaka K, Yamamoto O, Honda T. Pathophysiology of psoriasis: a review. J Dermatol. 2021, 48:722-31. 10.1111\/1346-8138.15913","journal-title":"J Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2018.11.005","article-title":"Il-23\/Th17 cell pathway: a promising target to alleviate thymic inflammation maintenance in myasthenia gravis","volume":"98","author":"Villegas JA","year":"2019","unstructured":"Villegas JA, Bayer AC, Ider K, et al.. Il-23\/Th17 cell pathway: a promising target to alleviate thymic inflammation maintenance in myasthenia gravis. J Autoimmun. 2019, 98:59-73. 10.1016\/j.jaut.2018.11.005","journal-title":"J Autoimmun"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2019.116648","article-title":"Maintenance immunosuppression in myasthenia gravis, an update","volume":"410","author":"Morren J","year":"2020","unstructured":"Morren J, Li Y. Maintenance immunosuppression in myasthenia gravis, an update. J Neurol Sci. 2020, 410:116648. 10.1016\/j.jns.2019.116648","journal-title":"J Neurol Sci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/89642-psoriasis-and-myasthenia-gravis-a-common-th-17-pathway","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:37:57Z","timestamp":1707507477000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/89642-psoriasis-and-myasthenia-gravis-a-common-th-17-pathway"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,12]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.23090","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3,12]]}}}